{"transactions":[{"id":671702,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-02T01:59:14.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":5083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026, granted under the Issuer's 2026 Omnibus Equity Incentive Plan. Subject to continued service, 100% of the stock options will vest on December 31, 2026."}],"balance_after":5083,"derivative":{"exercise_price":4.57,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":5083},"source":{"system":"sec-edgar","filing":"0001493152-26-041137","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315226041137/ownership.xml","form_type":"4"}},{"id":671701,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-02T01:59:14.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":8320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter."}],"balance_after":8320,"derivative":{"exercise_price":4.57,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":8320},"source":{"system":"sec-edgar","filing":"0001493152-26-041137","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315226041137/ownership.xml","form_type":"4"}},{"id":724092,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-29T23:03:08.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":29888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":29888,"derivative":{"exercise_price":16.01,"exercise_date":"2027-06-26","expiration_date":"2036-06-26","underlying":"Common Stock","underlying_shares":29888},"source":{"system":"sec-edgar","filing":"0001193125-26-288902","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000119312526288902/ownership.xml","form_type":"4"}},{"id":951700,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T14:00:10.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":37762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date."}],"balance_after":37762,"derivative":{"exercise_price":3.72,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":37762},"source":{"system":"sec-edgar","filing":"0001193125-26-001611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000119312526001611/ownership.xml","form_type":"4"}},{"id":1101089,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-26T20:24:21.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":1.45,"exercise_date":"2026-06-24","expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000950170-25-090418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000095017025090418/ownership.xml","form_type":"4"}},{"id":1278031,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-02-11T00:00:10.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":72074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter."}],"balance_after":72074,"derivative":{"exercise_price":0.34,"expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":72074},"source":{"system":"sec-edgar","filing":"0001493152-25-005720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315225005720/ownership.xml","form_type":"4"}},{"id":1318727,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T01:14:58.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":45678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2025 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date."}],"balance_after":45678,"derivative":{"exercise_price":2.51,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":45678},"source":{"system":"sec-edgar","filing":"0000950170-25-000630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000095017025000630/ownership.xml","form_type":"4"}},{"id":1472130,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T12:41:02.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 20, 2025, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.03,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-24-005920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919124005920/doc4.xml","form_type":"4"}},{"id":1482929,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:37:56.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":false,"nature":"By Bristol Survivor's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":14.91,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-072206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072206/ownership.xml","form_type":"4"}},{"id":1482928,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:37:56.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18500,"ownership":{"direct":false,"nature":"By Bristol Survivor's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":13.98,"underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0000950170-24-072206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072206/ownership.xml","form_type":"4"}},{"id":1482927,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:37:56.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9570,"ownership":{"direct":false,"nature":"By Bristol Survivor's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":8.27,"underlying":"Common Stock","underlying_shares":9570},"source":{"system":"sec-edgar","filing":"0000950170-24-072206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072206/ownership.xml","form_type":"4"}},{"id":1482926,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:37:56.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12000,"ownership":{"direct":false,"nature":"By Bristol Survivor's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":21.05,"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000950170-24-072206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072206/ownership.xml","form_type":"4"}},{"id":1482925,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:37:56.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":67494,"ownership":{"direct":false,"nature":"By Bristol Survivor's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":6.13,"underlying":"Common Stock","underlying_shares":67494},"source":{"system":"sec-edgar","filing":"0000950170-24-072206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072206/ownership.xml","form_type":"4"}},{"id":1482924,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:37:56.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22150,"ownership":{"direct":false,"nature":"By Bristol Survivor's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 29, 2024, by and among the Issuer, Ono Pharmaceutical Co., Ltd. (\"Parent\"), and Topaz Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.01 per share for a price per share of $25.60, without interest and subject to tax withholding (the \"Merger Consideration\"). Effective as of June 11, 2024 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation in the Merger and as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding stock option of the Issuer having an exercise price per share that is less than the Merger Consideration became fully vested, and was cancelled and automatically converted into the right to receive an amount in cash equal to (A) the number of shares underlying such option multiplied by (B) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":3.95,"underlying":"Common Stock","underlying_shares":22150},"source":{"system":"sec-edgar","filing":"0000950170-24-072206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000095017024072206/ownership.xml","form_type":"4"}},{"id":1534303,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-04-29T20:30:47.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":124525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest as to 100% of the number of shares subject to the stock option on the one-year anniversary of the grant date."}],"balance_after":124525,"derivative":{"exercise_price":1.74,"expiration_date":"2034-04-26","underlying":"Common Stock","underlying_shares":124525},"source":{"system":"sec-edgar","filing":"0001140361-24-023011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036124023011/form4.xml","form_type":"4"}},{"id":1692794,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T14:00:14.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments beginning one month from the date of grant, subject to such person's continuing in service on the board through the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the election of the filing person, the option grant was issued in lieu of direct cash compensation payable to such person in 2024 in connection with each position on the board and its committees for which such person is anticipated to serve in 2024."}],"balance_after":62747,"derivative":{"exercise_price":2.13,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":62747},"source":{"system":"sec-edgar","filing":"0001209191-24-000272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919124000272/doc4.xml","form_type":"4"}},{"id":1844259,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T13:09:06.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 22, 2024, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":2.66,"exercise_date":"2024-06-22","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-039582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919123039582/doc4.xml","form_type":"4"}},{"id":1844851,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-23T16:05:21.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 21, 2024, subject to continued service through such date."}],"balance_after":30000,"derivative":{"exercise_price":14.91,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-039331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919123039331/doc4.xml","form_type":"4"}},{"id":2077702,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-23T02:26:16.000Z","date":"2022-12-21","kind":"purchase","acquired":true,"shares":20000,"price":4.14,"value":82800.0,"ownership":{"direct":false,"nature":"By Bristol Survivor?s Trust, Dated October 26, 2019"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein as being purchased were purchased by the Bristol Survivor's Trust Dated October 26, 2019.  Such securities may be deemed to be beneficially owned by the Reporting Person, who is the trustee of the Bristol Survivor's Trust Dated October 26, 2019."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-22-062536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919122062536/doc4.xml","form_type":"4"}},{"id":2221743,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T16:05:50.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 23, 2023, subject to continued service through such date."}],"balance_after":18500,"derivative":{"exercise_price":13.98,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-22-039199","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919122039199/doc4.xml","form_type":"4"}},{"id":2222123,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T13:17:04.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options to purchase shares vest on June 22, 2023, subject to the Reporting Person's continuous service to the Issuer on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.35,"exercise_date":"2023-06-22","expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-039101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000120919122039101/doc4.xml","form_type":"4"}},{"id":2429664,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T17:01:24.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":9570,"price":5.22,"value":49955.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2022 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy.  2,393 shares will vest on March 31, 2022, 2,393 shares will vest on June 30, 2022, 2,393 shares will vest on September 30, 2022 and the remaining 2,391 shares will vest on December 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2022 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy.  2,393 shares will vest on March 31, 2022, 2,393 shares will vest on June 30, 2022, 2,393 shares will vest on September 30, 2022 and the remaining 2,391 shares will vest on December 31, 2022."}],"balance_after":9570,"derivative":{"exercise_price":8.27,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":9570},"source":{"system":"sec-edgar","filing":"0001209191-22-004086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919122004086/doc4.xml","form_type":"4"}},{"id":2654385,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T16:00:38.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 23, 2022, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":35.86,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-043273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121043273/doc4.xml","form_type":"4"}},{"id":2742704,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T16:30:15.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable as of July 31, 2020."}],"balance_after":22150,"derivative":{"exercise_price":3.95,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001209191-21-027789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121027789/doc4.xml","form_type":"4"}},{"id":2742703,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-21T16:30:15.000Z","date":"2021-04-19","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable as of July 31, 2020."}],"balance_after":23850,"derivative":{"exercise_price":3.95,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-21-027789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121027789/doc4.xml","form_type":"4"}},{"id":2742702,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:30:15.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":1700,"price":45.5963,"value":77513.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.53 to $45.735, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-027789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121027789/doc4.xml","form_type":"4"}},{"id":2742701,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:30:15.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":1700,"price":3.95,"value":6715.0,"ownership":{"direct":true},"balance_after":1700,"source":{"system":"sec-edgar","filing":"0001209191-21-027789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121027789/doc4.xml","form_type":"4"}},{"id":2742700,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:30:15.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":1300,"price":46.6631,"value":60662.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.03, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-027789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121027789/doc4.xml","form_type":"4"}},{"id":2742699,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:30:15.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":4000,"price":46.1295,"value":184518.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.48, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-21-027789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121027789/doc4.xml","form_type":"4"}},{"id":2742698,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T16:30:15.000Z","date":"2021-04-19","kind":"exercise","acquired":true,"shares":5300,"price":3.95,"value":20935.0,"ownership":{"direct":true},"balance_after":5300,"source":{"system":"sec-edgar","filing":"0001209191-21-027789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121027789/doc4.xml","form_type":"4"}},{"id":2749222,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-14T16:00:20.000Z","date":"2021-04-12","kind":"exercise","acquired":false,"shares":14700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable as of July 31, 2020."}],"balance_after":29150,"derivative":{"exercise_price":3.95,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":14700},"source":{"system":"sec-edgar","filing":"0001209191-21-026633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121026633/doc4.xml","form_type":"4"}},{"id":2749221,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T16:00:20.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":5217,"price":44.0944,"value":230040.4848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.01 to $44.36, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-026633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121026633/doc4.xml","form_type":"4"}},{"id":2749220,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T16:00:20.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":9483,"price":43.6961,"value":414370.1163,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $44.00, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":5217,"source":{"system":"sec-edgar","filing":"0001209191-21-026633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121026633/doc4.xml","form_type":"4"}},{"id":2749219,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T16:00:20.000Z","date":"2021-04-12","kind":"exercise","acquired":true,"shares":14700,"price":3.95,"value":58065.0,"ownership":{"direct":true},"balance_after":14700,"source":{"system":"sec-edgar","filing":"0001209191-21-026633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121026633/doc4.xml","form_type":"4"}},{"id":2901529,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T16:00:09.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable as of July 31, 2020."}],"balance_after":43850,"derivative":{"exercise_price":3.95,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-004246","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121004246/doc4.xml","form_type":"4"}},{"id":2901528,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T16:00:09.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":600,"price":51.11,"value":30666.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.86 to $51.35, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-004246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121004246/doc4.xml","form_type":"4"}},{"id":2901527,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T16:00:09.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":6400,"price":50.2146,"value":321373.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.68 to $50.65, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001209191-21-004246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121004246/doc4.xml","form_type":"4"}},{"id":2901526,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-20T16:00:09.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":7000,"price":3.95,"value":27650.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-21-004246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919121004246/doc4.xml","form_type":"4"}},{"id":3007831,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T16:20:09.000Z","date":"2020-10-09","kind":"exercise","acquired":false,"shares":23541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":0,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":23541},"source":{"system":"sec-edgar","filing":"0001209191-20-054633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120054633/doc4.xml","form_type":"4"}},{"id":3007830,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T16:20:09.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":200,"price":55.43,"value":11086.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.13 to $55.73, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-054633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120054633/doc4.xml","form_type":"4"}},{"id":3007829,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T16:20:09.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":3971,"price":54.5281,"value":216531.0851,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.13 to $55.12, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001209191-20-054633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120054633/doc4.xml","form_type":"4"}},{"id":3007828,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T16:20:09.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":19370,"price":53.3532,"value":1033451.484,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.10 to $54.05, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4171,"source":{"system":"sec-edgar","filing":"0001209191-20-054633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120054633/doc4.xml","form_type":"4"}},{"id":3007827,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T16:20:09.000Z","date":"2020-10-09","kind":"exercise","acquired":true,"shares":23541,"price":1.89,"value":44492.49,"ownership":{"direct":true},"balance_after":23541,"source":{"system":"sec-edgar","filing":"0001209191-20-054633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120054633/doc4.xml","form_type":"4"}},{"id":3080007,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-17T16:00:15.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":723,"price":34.58,"value":25001.34,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued upon election by the director to receive his cash board retainer fee for the second half of 2020 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy and 362 shares will vest on September 30, 2020 and 361 shares will vest on December 31, 2020, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company."}],"balance_after":723,"derivative":{"exercise_price":53.41,"expiration_date":"2030-07-15","underlying":"Common Stock","underlying_shares":723},"source":{"system":"sec-edgar","filing":"0001209191-20-042769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042769/doc4.xml","form_type":"4"}},{"id":3084142,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"exercise","acquired":false,"shares":7217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":23541,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":7217},"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3084141,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"exercise","acquired":false,"shares":16324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":0,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":16324},"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3084140,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":301,"price":57.0172,"value":17162.1772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.94 to $57.19, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3084139,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":1829,"price":56.2416,"value":102865.8864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.92 to $56.90, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":301,"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3084138,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":9050,"price":55.1503,"value":499110.215,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.90 to $55.85, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2130,"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3084137,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":12361,"price":54.6473,"value":675495.2753,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.90 to $54.88, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":11180,"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3084136,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"exercise","acquired":true,"shares":7217,"price":1.89,"value":13640.13,"ownership":{"direct":true},"balance_after":23541,"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3084135,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T16:11:14.000Z","date":"2020-07-09","kind":"exercise","acquired":true,"shares":16324,"price":1.89,"value":30852.36,"ownership":{"direct":true},"balance_after":16324,"source":{"system":"sec-edgar","filing":"0001209191-20-042243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120042243/doc4.xml","form_type":"4"}},{"id":3111406,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T16:00:26.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 10, 2021, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":56.46,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-036239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120036239/doc4.xml","form_type":"4"}},{"id":3177618,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T19:47:19.000Z","date":"2020-04-09","kind":"exercise","acquired":false,"shares":23542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":16324,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":23542},"source":{"system":"sec-edgar","filing":"0001209191-20-024252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120024252/doc4.xml","form_type":"4"}},{"id":3177617,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:47:19.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":536,"price":45.8835,"value":24593.556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.46 to $45.99, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-024252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120024252/doc4.xml","form_type":"4"}},{"id":3177616,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:47:19.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":11012,"price":44.1775,"value":486482.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.45 to $45.34, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":536,"source":{"system":"sec-edgar","filing":"0001209191-20-024252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120024252/doc4.xml","form_type":"4"}},{"id":3177615,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:47:19.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":5621,"price":43.9275,"value":246916.4775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.43 to $44.39, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":11548,"source":{"system":"sec-edgar","filing":"0001209191-20-024252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120024252/doc4.xml","form_type":"4"}},{"id":3177614,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:47:19.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":6373,"price":42.9699,"value":273847.1727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.43 to $43.41, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":17169,"source":{"system":"sec-edgar","filing":"0001209191-20-024252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120024252/doc4.xml","form_type":"4"}},{"id":3177613,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T19:47:19.000Z","date":"2020-04-09","kind":"exercise","acquired":true,"shares":23542,"price":1.89,"value":44494.38,"ownership":{"direct":true},"balance_after":23542,"source":{"system":"sec-edgar","filing":"0001209191-20-024252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120024252/doc4.xml","form_type":"4"}},{"id":3317433,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-03","kind":"exercise","acquired":false,"shares":7989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":39866,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":7989},"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317432,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":15553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":47855,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":15553},"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317431,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":200,"price":58.72,"value":11744.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.70 to $58.75, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317430,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":1810,"price":58.1667,"value":105281.727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.66 to $58.65, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317429,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":5250,"price":57.2138,"value":300372.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.63 to $57.57, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2010,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317428,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":729,"price":55.9634,"value":40797.3186,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.55 to $56.38, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7260,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317427,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-03","kind":"exercise","acquired":true,"shares":7989,"price":1.89,"value":15099.21,"ownership":{"direct":true},"balance_after":7989,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317426,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":300,"price":61.87,"value":18561.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.68 to $62.25, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317425,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":365,"price":59.3842,"value":21675.233,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.17 to $59.56, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317424,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":5347,"price":58.0824,"value":310566.5928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.87 to $58.73, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":665,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317423,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":9541,"price":57.506,"value":548664.746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.87 to $57.86, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6012,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3317422,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:15:15.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":15553,"price":1.89,"value":29395.17,"ownership":{"direct":true},"balance_after":15553,"source":{"system":"sec-edgar","filing":"0001209191-20-001755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919120001755/doc4.xml","form_type":"4"}},{"id":3379715,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-05T16:16:16.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":63408,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-055179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119055179/doc4.xml","form_type":"4"}},{"id":3379714,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-05T16:16:16.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":25000,"price":45.0729,"value":1126822.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.4650, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-055179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119055179/doc4.xml","form_type":"4"}},{"id":3379713,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-05T16:16:16.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":25000,"price":1.89,"value":47250.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-19-055179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119055179/doc4.xml","form_type":"4"}},{"id":3439643,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-13T19:51:17.000Z","date":"2019-08-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":88408,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-045816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119045816/doc4.xml","form_type":"4"}},{"id":3439642,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T19:51:17.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":100,"price":42.9,"value":4290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-045816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119045816/doc4.xml","form_type":"4"}},{"id":3439641,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T19:51:17.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":700,"price":42.0501,"value":29435.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.67 to $42.53, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-19-045816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119045816/doc4.xml","form_type":"4"}},{"id":3439640,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T19:51:17.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":12687,"price":40.5015,"value":513842.5305,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.13 to $41.01, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001209191-19-045816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119045816/doc4.xml","form_type":"4"}},{"id":3439639,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T19:51:17.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":11513,"price":39.2424,"value":451797.7512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.10 to $40.00, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":13487,"source":{"system":"sec-edgar","filing":"0001209191-19-045816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119045816/doc4.xml","form_type":"4"}},{"id":3439638,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T19:51:17.000Z","date":"2019-08-13","kind":"exercise","acquired":true,"shares":25000,"price":1.89,"value":47250.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-19-045816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119045816/doc4.xml","form_type":"4"}},{"id":3490856,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T16:11:05.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan.  The option shall vest in full on June 11, 2020, subject to continued service through such date."}],"balance_after":12000,"derivative":{"exercise_price":21.05,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-036742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119036742/doc4.xml","form_type":"4"}},{"id":3648872,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T19:25:41.000Z","date":"2019-02-15","kind":"exercise","acquired":false,"shares":17782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable\non the date of grant, December 18, 2015."}],"balance_after":113408,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":17782},"source":{"system":"sec-edgar","filing":"0001209191-19-011360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119011360/doc4.xml","form_type":"4"}},{"id":3648871,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T19:25:41.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":1101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable\non the date of grant, December 18, 2015."}],"balance_after":131190,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":1101},"source":{"system":"sec-edgar","filing":"0001209191-19-011360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119011360/doc4.xml","form_type":"4"}},{"id":3648870,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T19:25:41.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":17782,"price":28.0398,"value":498603.7236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.06, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-011360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119011360/doc4.xml","form_type":"4"}},{"id":3648869,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T19:25:41.000Z","date":"2019-02-15","kind":"exercise","acquired":true,"shares":17782,"price":1.89,"value":33607.98,"ownership":{"direct":true},"balance_after":17782,"source":{"system":"sec-edgar","filing":"0001209191-19-011360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119011360/doc4.xml","form_type":"4"}},{"id":3648868,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T19:25:41.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":1101,"price":28.0126,"value":30841.8726,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to\n$28.04, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-011360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119011360/doc4.xml","form_type":"4"}},{"id":3648867,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T19:25:41.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":1101,"price":1.89,"value":2080.89,"ownership":{"direct":true},"balance_after":1101,"source":{"system":"sec-edgar","filing":"0001209191-19-011360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119011360/doc4.xml","form_type":"4"}},{"id":3655860,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-14T16:22:28.000Z","date":"2019-02-13","kind":"exercise","acquired":false,"shares":2922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":132291,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":2922},"source":{"system":"sec-edgar","filing":"0001209191-19-010144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119010144/doc4.xml","form_type":"4"}},{"id":3655859,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-14T16:22:28.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":135213,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001209191-19-010144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119010144/doc4.xml","form_type":"4"}},{"id":3655858,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T16:22:28.000Z","date":"2019-02-13","kind":"sale","acquired":false,"shares":2922,"price":28.0067,"value":81835.5774,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.07, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-010144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119010144/doc4.xml","form_type":"4"}},{"id":3655857,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T16:22:28.000Z","date":"2019-02-13","kind":"exercise","acquired":true,"shares":2922,"price":1.89,"value":5522.58,"ownership":{"direct":true},"balance_after":2922,"source":{"system":"sec-edgar","filing":"0001209191-19-010144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119010144/doc4.xml","form_type":"4"}},{"id":3655856,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T16:22:28.000Z","date":"2019-02-12","kind":"sale","acquired":false,"shares":600,"price":28.0017,"value":16801.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.01, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-010144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119010144/doc4.xml","form_type":"4"}},{"id":3655855,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T16:22:28.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":600,"price":1.89,"value":1134.0,"ownership":{"direct":true},"balance_after":600,"source":{"system":"sec-edgar","filing":"0001209191-19-010144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119010144/doc4.xml","form_type":"4"}},{"id":3669972,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-07T16:09:25.000Z","date":"2019-02-05","kind":"exercise","acquired":false,"shares":2595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015."}],"balance_after":135813,"derivative":{"exercise_price":1.89,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":2595},"source":{"system":"sec-edgar","filing":"0001209191-19-008046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119008046/doc4.xml","form_type":"4"}},{"id":3669971,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-07T16:09:25.000Z","date":"2019-02-05","kind":"sale","acquired":false,"shares":2595,"price":28.017,"value":72704.115,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.08, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-008046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119008046/doc4.xml","form_type":"4"}},{"id":3669970,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-07T16:09:25.000Z","date":"2019-02-05","kind":"exercise","acquired":true,"shares":2595,"price":1.89,"value":4904.55,"ownership":{"direct":true},"balance_after":2595,"source":{"system":"sec-edgar","filing":"0001209191-19-008046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000120919119008046/doc4.xml","form_type":"4"}},{"id":3923428,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-21T16:23:12.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award was issued pursuant to Issuer's 2017 Stock Option and Incentive Plan and will vest in full on May 17, 2019, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":12000,"derivative":{"exercise_price":25.73,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-18-013548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000089924318013548/doc4.xml","form_type":"4"}},{"id":4197297,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T16:41:14.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":67494,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the total number of options to purchase common stock of the Issuer received upon the exchange of options to purchase common stock of Deciphera Pharmaceuticals, Inc. for options to purchase common stock of the Issuer pursuant to the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan.  The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of May 26, 2017, subject to continued service through"}],"balance_after":67494,"derivative":{"exercise_price":6.13,"expiration_date":"2027-06-03","underlying":"Common Stock","underlying_shares":67494},"source":{"system":"sec-edgar","filing":"0000899243-17-023139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000089924317023139/doc4.xml","form_type":"4"}},{"id":4197296,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T16:41:14.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":11946,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan.  The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of May 26, 2017, subject to continued service through"}],"balance_after":0,"derivative":{"exercise_price":6.13,"expiration_date":"2027-06-03","underlying":"Common Stock","underlying_shares":67494},"source":{"system":"sec-edgar","filing":"0000899243-17-023139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000089924317023139/doc4.xml","form_type":"4"}},{"id":4197295,"issuer":{"id":90033,"kind":"organization","name":"Deciphera Pharmaceuticals, Inc.","symbol":"NA"},"owners":[{"id":18227,"kind":"person","name":"Bristol James Arthur","position":1,"cik":"0001715153","reported_name":"Bristol James Arthur","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T16:41:14.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":50850,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the total number of options to purchase common stock of the Issuer received upon the exchange of options to purchase common stock of Deciphera Pharmaceuticals, Inc. for options to purchase common stock of the Issuer pursuant to the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, these options to purchase common stock of Deciphera Pharmaceuticals, LLC were exchanged for options to purchase common stock of the Issuer on a 1 for 5.65 basis pursuant to that certain Reorganization Agreement and Plan of Merger by and among the Issuer, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated September 26, 2017 (the \"Merger Agreement\"). These transactions were exempt from Section 16(b) in reliance upon Rule 16b-3 and Rule 16b-6(b)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan.  The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of July 1, 2016, subject to continued service through such dates."}],"balance_after":50580,"derivative":{"exercise_price":3.95,"expiration_date":"2026-09-26","underlying":"Common Stock","underlying_shares":50580},"source":{"system":"sec-edgar","filing":"0000899243-17-023139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654151/000089924317023139/doc4.xml","form_type":"4"}}],"next_cursor":"2017-10-02T16:41:14.000000Z,4197295"}